Antibacterial polymer for hospital microbes from chemistry graduate students. The product developed by students who continue their postgraduate education at Istanbul Technical and Boğaziçi Universities, can eliminate all the most known hospital microbes even at low concentrations, and does not pass into the body through the skin.
Boğaziçi University Chemistry Department graduate student Bıçak said, “We have applied for a patent. If this project is implemented, hospital-acquired infections and related deaths will be greatly reduced. The best of these antibacterial substances, all of which are imported from abroad, can be produced in our country and exported abroad.
Two students from Turkey developed an antibacterial product that has a killing effect on the bacterium, 'Pseudomonas aeruginosa', the most known of the hospital microbes. Antibacterial polymer, developed by ITU Chemistry Department doctoral student Ahmet İnce and Boğaziçi University Chemistry Department graduate student Tuğrul Cem Bıçak, came second in the ITU Arı Çekirdek Project competition, which encourages the development of projects aimed at eliminating Turkey's dependence on foreign sources in different fields.
Cem Bıçak stated that the importance of social hygiene has increased even more, considering the increasing environmental pollution in the world and epidemics such as swine flu that occur periodically.
Explaining that they decided to develop such a product based on the importance of antibacterial products, Bıçak said that the chemical compounds of antibacterial products in Turkey were purchased from abroad.
Pointing out that the number of antibacterial substances known in the world is limited, Bıçak said that these substances are also patented by the world's leading companies. Indicating that it is almost impossible to produce other than these, Bıçak said, “The material we have developed is different from the anti-bacterial materials currently used in the world, it has a patentable feature and the production cost is low. Moreover, it has been documented that this substance is more effective than existing antibacterial chemicals, as a result of standard tests conducted at Uludag University.
No skin-to-body transmission
Pointing out that, according to a study, more than 100 thousand patients in the United States die from infections annually, the bacteria Pseudomonas aeruginosa, also known as the hospital microbe, is largely responsible, said Bıçak:
“Even if the current sterilization processes are applied flawlessly, the risk of 30 percent infection cannot be avoided. It has been reported that the antibacterial product we have developed has a killing effect on all Pseudomonas aeruginosa bacteria, even at very low concentrations. Another important feature of the product we have developed is that it is polymeric. Today, triclosan and other small-structured compounds, which are abundant in many products sold under the name of antibacterial, enter the body through the skin and leave harmful effects, and their use is gradually banned all over the world. They are being replaced by polymeric materials that cannot pass through the skin, and the work done today is aimed at the development of such products.”
We have applied for a patent
Indicating that they have applied for a patent, Bıçak added that if the project is implemented, first of all, hospital-acquired infections and related deaths will be greatly reduced, and that better antibacterial agents, all of which are currently imported from abroad, can be produced in Turkey and exported abroad.
source : hurriyet